Concepedia

Heming Xia

HX

Statistics

Publications

15

Citations

1.1K

H-Index

13

Active since

2017

Affiliations

Peking University(Current)

Peking University First Hospital

China Pharmaceutical University

Heming Xia is an author at Peking University specializing in nanomedicine, oncology, and cancer nanomedicine.

ORCID

Publications per year

2017–2025

15

Publications

15

A Survey on In-context Learning

Qingxiu Dong, Lei Li, Damai Dai et al. · 2024 · 509 citations · Full text

, , +12

A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination

Heming Xia, Mengmeng Qin, Zenghui Wang et al. · Nano Letters · 2022 · 101 citations

, , +17

pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy

Mingmei Tang, Binlong Chen, Heming Xia et al. · Nature Communications · 2023 · 86 citations · Full text

, , +17

Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy

Yaoqi Wang, Zenghui Wang, Binlong Chen et al. · Nano Letters · 2021 · 71 citations

, , +17

pH‐Amplified CRET Nanoparticles for In Vivo Imaging of Tumor Metastatic Lymph Nodes

Zenghui Wang, Heming Xia, Binlong Chen et al. · Angewandte Chemie International Edition · 2021 · 68 citations

, , +17

1–5 of 15